Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01279226 · ClinicalTrials.gov registry record · NA
Investigation of Radiofrequency Device for Treatment of Wrinkles and Rhytides
A NA study of Laxity of Skin, sponsored by Rocky Mountain Biosystems.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01279226: Completed NA study of Laxity of Skin, sponsored by Rocky Mountain Biosystems.
NCT01279226 is a NA study of Laxity of Skin that has completed, run by Rocky Mountain Biosystems. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01279226, a NA study of Laxity of Skin, has completed, sponsored by Rocky Mountain Biosystems.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot research study is to collect information on the safety and effectiveness of an experimental device intended to be used to improve the appearance of the skin by reducing the visibility of wrinkles and by reducing the looseness of skin.
Primary Outcome
Photographs of subjects before and after treatment will be scored and compared. Histology of skin samples may be used to assess deleterious events and elucidate the operative mechanism.
Conditions Studied
Interventions
- DEVICE Auralevée device
Study Locations (1)
Washington
- Laser Treatment Center - Kirkland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-02 |
| Phase | NA |
What the finished NCT01279226 record still lists
NCT01279226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Laxity of Skin appearing as the primary indexed condition, and to 1 intervention - of which Auralevée device is the first listed.
NCT01279226 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT01279226 about?
NCT01279226 is a clinical study titled "Investigation of Radiofrequency Device for Treatment of Wrinkles and Rhytides". The purpose of this pilot research study is to collect information on the safety and effectiveness of an experimental device intended to be used to improve the appearance of the skin by reducing the visibility of wrinkles and by reducing the looseness of skin.
What is the current status of trial NCT01279226?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2010-02. Estimated completion is 2011-02.
What conditions does trial NCT01279226 study?
This clinical trial studies the following conditions: Laxity of Skin.
What interventions are being tested in trial NCT01279226?
The interventions under investigation include: Auralevée device (DEVICE).
Who is sponsoring clinical trial NCT01279226?
This trial is sponsored by Rocky Mountain Biosystems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01279226 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01279226's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia